🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The 11th publication from the iStopMM study, is a collaborative work and published in Communications Medicine, investigates the long-term physical and cognitive impact of SARS-CoV-2 infection in a large population-based study. 🦠🧠 #iStopMM #LongCovid

The 12th publication from the iStopMM study, published in Haematologica, highlights the importance of using screened cohorts to study disease associations with MGUS and estimates the selection bias in previous clinical studies. 🩸📊 #iStopMM #MultipleMyeloma International Myeloma Foundation

The 13th publication from the iStopMM study, published in Blood Cancer Journal in 2023, presents a novel bone marrow quality index (BMQI) to assess hemodilution in bone marrow (BM) aspirates for plasma cell disorders. 🩸📊 #iStopMM #MultipleMyeloma Led by Jón Þórir Óskarsson 🧵

The 14th publication from the iStopMM study, published in Blood Cancer Journal (2023), investigates the immunophenotypic profile of early-stage monoclonal gammopathies using high-sensitivity next-generation flow cytometry (NGF). 🩸🔬 #iStopMM #MultipleMyeloma #mmsm International Myeloma Foundation

The 15th publication from the iStopMM study, published in @EURPUB_HSJ in 2023, investigates trends of perceived disruption in healthcare services during the COVID-19 pandemic in Iceland and its association with socio-demographic factors and pre-existing health conditions. 🏥📊

The 16th publication from the iStopMM study, published in Clinical Chemistry in 2024, reviews the current evidence on screening for multiple myeloma (MM) and its precursors, evaluating whether screening meets established criteria for implementation🩸 #iStopMM #mmsm Sæmundur Rögnvaldsson, MD, PhD

The 17th publication from the iStopMM study, published in Haematologica in 2024, investigates the association between prior cancer and the risk of developing MGUS, as well as MGUS progression. 🩸📊 #iStopMM #MultipleMyeloma #mmsm Sæmundur Rögnvaldsson, MD, PhD

The 18th publication from the iStopMM study, published in Annals of Int Med in 2024, presents a multivariable model to predict the need for bone marrow (BM) sampling in individuals with monoclonal gammopathy of undetermined significance (MGUS). 🩸📈 #iStopMM #MGUS International Myeloma Foundation

The 20th publication from the iStopMM study, a collaborative effort published in Nature Communications in 2024, explores genetic factors underlying multiple myeloma (MM) risk through a genome-wide association study (GWAS). 🧬🔍 #iStopMM #mmsm International Myeloma Foundation

Calling all myeloma experts, nurses, and patients!🩺🧬 The iStopMM team & International Myeloma Foundation need your input: When should we do a bone marrow biopsy in MGUS? 📋 Anonymous 🕒 10 min 💡 impactful Take part & help spread the word: redcap.link/biopsysurvey #Myeloma #mmsm

This right here #mmsm peeps! 👇🏽😊

I hear all the cool 😎 ppl are filling out this survey, please fill and retweet! Myeloma Canada Raj Chakraborty Joshua Richter, MD, FACP Samer Al Hadidi, MD,MS,FACP Surbhi Sidana, MD Ben Derman Rahul Banerjee, MD, FACP Sigurdur Kristinsson

There’s no right answer, so tell us yours! Great to see iStopMM group at it again - patients, nurses, APPs, and physicians can fill out easy survey (written in patient-friendly language) about what % #MMsm risk and pt scenarios might prompt BMBx. redcap.link/biopsysurvey

Michael H. Tomasson, MD iStopMM International Myeloma Foundation That is the point. Should not represent current practice. We aim to be practice changing ;)

Calling all myeloma experts, nurses, and patients - Sigurdur Kristinsson iStopMM International Myeloma Foundation oncodaily.com/blog/sigurdur-… #IMF #MGUS #Cancer #OncoDaily #Medicine #Oncology #MedEd #MedX #MedNews

The 21st publication from the iStopMM study, published in Archives of Dermatological Research in 2024, investigates the potential association between monoclonal gammopathies (MGUS, SMM, MM) and alopecia (hair loss). 📊🔬 #iStopMM #dermatology

Thank you all for participating in our survey! It is still open for those that have not completed it yet. Your input is of great importance! Take part & help spread the word: redcap.link/biopsysurvey

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance iStopMM JAMA Oncology #mmsm jamanetwork.com/journals/jamao… Important data coming to support need for new ranges of normal free light chains based on eGFR👇

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance | Nephrology | JAMA Oncology | JAMA Network jamanetwork.com/journals/jamao…

🧵1/ Our paper is out! A new study from the iStopMM team in JAMA Oncology shows how revising free light chain (FLC) reference intervals can reduce false positives for light chain MGUS (LC-MGUS). Let’s break it down 👇 jamanetwork.com/journals/jamao…